Ignite Creation Date:
2025-12-25 @ 1:59 AM
Ignite Modification Date:
2026-01-21 @ 10:03 PM
Study NCT ID:
NCT04595994
Status:
RECRUITING
Last Update Posted:
2024-01-23
First Post:
2020-10-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma
Sponsor:
Grupo Espanol de Investigacion en Sarcomas
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Sarcoma,Soft Tissue | View |
Keywords: